Medicinal cannabinoids are helpful for treatment of spasticity, pain, and bladder dysfunction for patients with multiple sclerosis (MS), although their efficacy is "limited," new research suggests.

A study published in the Journal of Clinical Medicine indicated that vaporized cannabis containing standardized percentages of cannabidiol (CBD) and tetrahydrocannabinol (THC) produced sustained ...

The case series found consistent improvements in outcomes, demonstrating a unique use in management of MS symptoms AUSTIN, Texas, Aug. 24, 2023 /PRNewswire/ -- A case series conducted by Dr. Courtney ...

LONDON, July 28 (Reuters) - GW Pharmaceuticals Plc's cannabis-derived medicine Sativex has been approved in its second European market, Spain, as an add-on therapy for treating spasticity in patients ...

WILMINGTON, N.C.--(BUSINESS WIRE)--Osmotica Pharmaceutical announced today that recruitment has begun for a Phase 3 clinical trial designed to assess the safety and efficacy of Arbaclofen Extended ...

There is currently no cure for Multiple Sclerosis (MS). Patients rarely do well with no therapy at all, and it is generally recommended that patients with a confident diagnosis of MS begin treatment ...

AUSTIN, Texas, Aug. 24, 2023 /PRNewswire/ -- A case series conducted by Dr. Courtney Ellerbusch, PT, DPT, of Centura Home Health (Colorado) on MS patients finds quantitative improvements in strength, ...